Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Rullan

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Cancer Research Communications|October 22, 2025
Xevinapant plus chemoradiotherapy negatively sculpts the tumour immune microenvironment in head and neck cancerCharleen Chan Wah Hak, Emmanuel C Patin, Anton Patrikeev, et al.
Nature Communications|August 12, 2024
Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent adjuvant immunotherapyEmmanuel C Patin, Pablo Nenclares, Charleen Chan Wah Hak, et al.
Nature Communications|July 8, 2025
The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse modelsJoan Kyula-Currie, Victoria Roulstone, James Wright, et al.
Nature Communications|May 24, 2025
Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasionVictoria Roulstone, Joan Kyula-Currie, James Wright, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Cancer Research Communications|October 22, 2025
Xevinapant plus chemoradiotherapy negatively sculpts the tumour immune microenvironment in head and neck cancerCharleen Chan Wah Hak, Emmanuel C Patin, Anton Patrikeev, et al.
Nature Communications|August 12, 2024
Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent adjuvant immunotherapyEmmanuel C Patin, Pablo Nenclares, Charleen Chan Wah Hak, et al.
Nature Communications|July 8, 2025
The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse modelsJoan Kyula-Currie, Victoria Roulstone, James Wright, et al.
Nature Communications|May 24, 2025
Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasionVictoria Roulstone, Joan Kyula-Currie, James Wright, et al.
Pageof 3